The move clears a path for the OxyContin maker to exit its six-year bankruptcy and resolve mass lawsuits.
Becky Yerak is a Bankruptcy Reporter at The Wall Street Journal. She covers law and legal affairs with a focus on litigation, bringing insights into the complexities of bankruptcy cases. Her work has been featured in Financial News, MarketWatch, Yahoo Finance, LiveMint, and The Wall Street Journal.






